Annual Drug Patent Expirations for CARDENE
Cardene is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are four patents protecting this drug and five Paragraph IV challenges.
The generic ingredient in CARDENE is nicardipine hydrochloride. Two suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
